Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
BioAtla Inc (NASDAQ: BCAB) closed the day trading at $0.34 up 1.58% from the previous closing price of $0.34. In other words, the price has increased by $1.58 from its previous closing price. On the day, 1.22 million shares were traded. BCAB stock price reached its highest trading level at $0.3665 during the session, while it also had its lowest trading level at $0.3254.
Ratios:
For a better understanding of BCAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On September 15, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.
Credit Suisse Downgraded its Outperform to Neutral on May 05, 2022, whereas the target price for the stock was revised from $35 to $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 19938098 and an Enterprise Value of -11870888. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 36.42. Its current Enterprise Value per Revenue stands at -1.079 whereas that against EBITDA is 0.179.
Stock Price History:
The Beta on a monthly basis for BCAB is 0.89, which has changed by -0.8005848 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, BCAB has reached a high of $2.53, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -16.56%, while the 200-Day Moving Average is calculated to be -57.91%.
Shares Statistics:
Over the past 3-months, BCAB traded about 609.48K shares per day on average, while over the past 10 days, BCAB traded about 918860 shares per day. A total of 58.40M shares are outstanding, with a floating share count of 44.43M. Insiders hold about 23.95% of the company’s shares, while institutions hold 18.51% stake in the company. Shares short for BCAB as of 1751241600 were 4126301 with a Short Ratio of 6.77, compared to 1748563200 on 4237342. Therefore, it implies a Short% of Shares Outstanding of 4126301 and a Short% of Float of 7.920000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of BioAtla Inc (BCAB) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.19 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$0.84 and -$1.42 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$1.11, with 3.0 analysts recommending between -$0.58 and -$1.48.
